Everpar Advisors LLC Makes New Investment in Chemed Co. (NYSE:CHE)

Everpar Advisors LLC acquired a new position in Chemed Co. (NYSE:CHE) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 947 shares of the company’s stock, valued at approximately $554,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in CHE. Chicago Capital LLC purchased a new stake in Chemed in the 4th quarter worth about $1,170,000. Raymond James & Associates boosted its stake in shares of Chemed by 5.7% during the 4th quarter. Raymond James & Associates now owns 67,918 shares of the company’s stock valued at $39,715,000 after buying an additional 3,654 shares during the period. Ontario Teachers Pension Plan Board grew its holdings in shares of Chemed by 229.2% during the 3rd quarter. Ontario Teachers Pension Plan Board now owns 5,984 shares of the company’s stock valued at $3,110,000 after acquiring an additional 4,166 shares in the last quarter. Trust Point Inc. acquired a new position in shares of Chemed in the fourth quarter worth $2,325,000. Finally, Charles Schwab Investment Management Inc. raised its holdings in shares of Chemed by 1.3% during the third quarter. Charles Schwab Investment Management Inc. now owns 97,335 shares of the company’s stock worth $50,585,000 after acquiring an additional 1,283 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors.

Insider Activity

In related news, VP Brian C. Judkins sold 11,158 shares of the business’s stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $645.00, for a total value of $7,196,910.00. Following the sale, the vice president now owns 1,422 shares of the company’s stock, valued at approximately $917,190. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other Chemed news, VP Brian C. Judkins sold 11,158 shares of the firm’s stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $645.00, for a total value of $7,196,910.00. Following the completion of the sale, the vice president now owns 1,422 shares in the company, valued at approximately $917,190. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Spencer S. Lee sold 2,000 shares of the business’s stock in a transaction that occurred on Thursday, March 28th. The stock was sold at an average price of $641.65, for a total transaction of $1,283,300.00. Following the completion of the transaction, the executive vice president now owns 20,760 shares of the company’s stock, valued at approximately $13,320,654. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 15,808 shares of company stock worth $10,184,531. Company insiders own 3.32% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on CHE. Royal Bank of Canada upped their target price on Chemed from $604.00 to $712.00 and gave the stock an “outperform” rating in a research report on Monday, March 4th. Oppenheimer increased their price objective on Chemed from $625.00 to $650.00 and gave the stock an “outperform” rating in a report on Thursday, February 29th. Finally, StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research note on Saturday.

Chemed Stock Up 1.7 %

NYSE CHE traded up $9.64 during trading on Tuesday, hitting $580.70. The company’s stock had a trading volume of 127,237 shares, compared to its average volume of 81,035. Chemed Co. has a 52 week low of $492.84 and a 52 week high of $654.62. The firm has a market cap of $8.79 billion, a P/E ratio of 31.25, a price-to-earnings-growth ratio of 2.29 and a beta of 0.46. The firm has a 50 day moving average price of $619.79 and a 200 day moving average price of $594.55.

Chemed (NYSE:CHE) last announced its earnings results on Wednesday, April 24th. The company reported $4.68 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.09 by ($0.41). Chemed had a return on equity of 30.52% and a net margin of 12.36%. The company had revenue of $589.23 million for the quarter, compared to the consensus estimate of $587.18 million. On average, equities analysts expect that Chemed Co. will post 21.72 earnings per share for the current year.

Chemed Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, March 15th. Investors of record on Monday, February 26th were given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 0.28%. The ex-dividend date of this dividend was Friday, February 23rd. Chemed’s dividend payout ratio (DPR) is presently 8.61%.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.